{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:11:41Z","timestamp":1770354701501,"version":"3.49.0"},"reference-count":26,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"16","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,18]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Vaccines against coronavirus disease 2019 have a high level of efficacy and safety across all populations. However, numerous case series have been published on neurological disorders, including Bell\u2019s palsy, Guillain-Barre syndrome, transverse myelitis, and multiple sclerosis. The authors presented a case of trigeminal neuropathy after coronavirus vaccination in a patient who had undergone microvascular decompression (MVD) for trigeminal neuralgia (TN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>A 77-year-old woman presented with acute trigeminal neuropathy after receiving a Pfizer-BioNtech vaccination (tozinameran) against severe acute respiratory syndrome coronavirus 2. The patient had undergone MVD for TN and the facial pain completely disappeared. One month later, she received the first injection of the tozinameran vaccine. Twelve hours after vaccination, she presented with numbness and pain induced by touching any place on the entire right face. No eruption was observed on her face. The serum herpes zoster virus antibodies were confirmed within the normal range. Magnetic resonance imaging revealed no abnormalities. The authors suspected a right trigeminal neuropathy after vaccination. Administration of carbamazepine and pregabalin improved TN but facial numbness persisted, especially in the mandibular division.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>The coronavirus is a possible etiology of secondary trigeminal neuropathy in the case of MVD for TN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case22101","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T03:08:12Z","timestamp":1650251292000},"source":"Crossref","is-referenced-by-count":8,"title":["Trigeminal neuropathy after tozinameran vaccination against COVID-19 in postmicrovascular decompression for trigeminal neuralgia: illustrative case"],"prefix":"10.3171","volume":"3","author":[{"given":"Keisuke","family":"Onoda","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Sashida","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomihiro","family":"Wakamiya","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Michiwaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Shimoji","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Suehiro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Yamane","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatou","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"20","key":"b1","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2: preliminary report","volume":"383","author":"Jackson LA","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG,  An mRNA vaccine against SARS-CoV-2: preliminary report. N Engl J Med. 2020;383(20):1920\u20131931.10.1056\/NEJMoa202248334870807"},{"issue":"27","key":"b2","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack FP","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N,  Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u20132615.10.1056\/NEJMoa203457734870807"},{"issue":"1","key":"b3","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","article-title":"Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","volume":"22","author":"Wan EYF","year":"2022","unstructured":"Wan EYF, Chui CSL, Lai FTT,  Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. 2022;22(1):64\u201372.10.1016\/S1473-3099(21)00451-5"},{"issue":"3","key":"b4","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","article-title":"COVID-19 mRNA vaccination leading to CNS inflammation: a case series","volume":"269","author":"Khayat-Khoei M","year":"2022","unstructured":"Khayat-Khoei M, Bhattacharyya S, Katz J,  COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol. 2022;269(3):1093\u20131106.10.1007\/s00415-021-10780-7"},{"issue":"10269","key":"b5","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","article-title":"Oxford-AstraZeneca COVID-19 vaccine efficacy","volume":"397","author":"Knoll MD","year":"2021","unstructured":"Knoll MD, Wonodi C. Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021;397(10269):72\u201374.10.1016\/S0140-6736(20)32623-4"},{"issue":"1","key":"b6","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00415-021-10648-w","article-title":"First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine","volume":"269","author":"Havla J","year":"2022","unstructured":"Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, K\u00fcmpfel T. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol. 2022;269(1):55\u201358.10.1007\/s00415-021-10648-w"},{"issue":"1","key":"b7","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.4.JNS192780","article-title":"Earlier radiosurgery leads to better pain relief and less medication usage for trigeminal neuralgia patients: an international multicenter study","volume":"135","author":"Mureb M","year":"2020","unstructured":"Mureb M, Golub D, Benjamin C,  Earlier radiosurgery leads to better pain relief and less medication usage for trigeminal neuralgia patients: an international multicenter study. J Neurosurg. 2020;135(1):1\u20138.10.3171\/2020.4.JNS192780"},{"issue":"6","key":"b8","series-title":"BMJ Case Rep","doi-asserted-by":"publisher","first-page":"e242344","DOI":"10.1136\/bcr-2021-242344","article-title":"Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19","volume":"14","author":"Narasimhalu K","year":"2021","unstructured":"Narasimhalu K, Lee WC, Salkade PR, De Silva DA. Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19. BMJ Case Rep. 2021;14(6):e242344.10.1136\/bcr-2021-242344"},{"key":"b9","series-title":"J Neurovirol","article-title":"A case of trigeminal neuralgia developing after a COVID-19 vaccination","author":"Kaya A","year":"2021","unstructured":"Kaya A, Kaya SY. A case of trigeminal neuralgia developing after a COVID-19 vaccination. J Neurovirol. 2021."},{"issue":"5","key":"b10","series-title":"Praxis (Bern)","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1024\/0369-8394.91.5.159","article-title":"Vermutete neurologische Nebenwirkungen der FSME-Impfung: Erfahrung der Schweizerischen Arzneimittel-Nebenwirkungs-Zentrale (SANZ)","volume":"91","author":"Doser K","year":"2002","unstructured":"Doser K, Hartmann F. Vermutete neurologische Nebenwirkungen der FSME-Impfung: Erfahrung der Schweizerischen Arzneimittel-Nebenwirkungs-Zentrale (SANZ). Praxis (Bern). 2002;91(5):159\u2013162.10.1024\/0369-8394.91.5.159"},{"issue":"3","key":"b11","series-title":"Headache","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/head.14075","article-title":"Trigeminal neuralgia as the sole neurological manifestation of COVID-19: a case report","volume":"61","author":"Molina-Gil J","year":"2021","unstructured":"Molina-Gil J, Gonz\u00e1lez-Fern\u00e1ndez L, Garc\u00eda-Cabo C. Trigeminal neuralgia as the sole neurological manifestation of COVID-19: a case report. Headache. 2021;61(3):560\u2013562.10.1111\/head.14075"},{"issue":"7","key":"b12","series-title":"ACS Chem Neurosci","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig AM","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995\u2013998.10.1021\/acschemneuro.0c00122"},{"issue":"8","key":"b13","series-title":"Headache","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/head.13884","article-title":"COVID-19 and headache: a primer for trainees","volume":"60","author":"Bobker SM","year":"2020","unstructured":"Bobker SM, Robbins MS. COVID-19 and headache: a primer for trainees. Headache. 2020;60(8):1806\u20131811.10.1111\/head.13884"},{"issue":"20","key":"b1","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2: preliminary report","volume":"383","author":"Jackson LA","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG,  An mRNA vaccine against SARS-CoV-2: preliminary report. N Engl J Med. 2020;383(20):1920\u20131931.10.1056\/NEJMoa2022483"},{"issue":"27","key":"b2","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack FP","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N,  Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u20132615.10.1056\/NEJMoa2034577"},{"issue":"1","key":"b3","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","article-title":"Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","volume":"22","author":"Wan EYF","year":"2022","unstructured":"Wan EYF, Chui CSL, Lai FTT,  Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. 2022;22(1):64\u201372.10.1016\/S1473-3099(21)00451-5"},{"issue":"3","key":"b4","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","article-title":"COVID-19 mRNA vaccination leading to CNS inflammation: a case series","volume":"269","author":"Khayat-Khoei M","year":"2022","unstructured":"Khayat-Khoei M, Bhattacharyya S, Katz J,  COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol. 2022;269(3):1093\u20131106.10.1007\/s00415-021-10780-7"},{"issue":"10269","key":"b5","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","article-title":"Oxford-AstraZeneca COVID-19 vaccine efficacy","volume":"397","author":"Knoll MD","year":"2021","unstructured":"Knoll MD, Wonodi C. Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021;397(10269):72\u201374.10.1016\/S0140-6736(20)32623-4"},{"issue":"1","key":"b6","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00415-021-10648-w","article-title":"First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine","volume":"269","author":"Havla J","year":"2022","unstructured":"Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, K\u00fcmpfel T. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol. 2022;269(1):55\u201358.10.1007\/s00415-021-10648-w"},{"issue":"1","key":"b7","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.4.JNS192780","article-title":"Earlier radiosurgery leads to better pain relief and less medication usage for trigeminal neuralgia patients: an international multicenter study","volume":"135","author":"Mureb M","year":"2020","unstructured":"Mureb M, Golub D, Benjamin C,  Earlier radiosurgery leads to better pain relief and less medication usage for trigeminal neuralgia patients: an international multicenter study. J Neurosurg. 2020;135(1):1\u20138.10.3171\/2020.4.JNS192780"},{"issue":"6","key":"b8","series-title":"BMJ Case Rep","doi-asserted-by":"publisher","first-page":"e242344","DOI":"10.1136\/bcr-2021-242344","article-title":"Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19","volume":"14","author":"Narasimhalu K","year":"2021","unstructured":"Narasimhalu K, Lee WC, Salkade PR, De Silva DA. Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19. BMJ Case Rep. 2021;14(6):e242344.10.1136\/bcr-2021-242344"},{"key":"b9","series-title":"J Neurovirol","article-title":"A case of trigeminal neuralgia developing after a COVID-19 vaccination","author":"Kaya A","year":"2021","unstructured":"Kaya A, Kaya SY. A case of trigeminal neuralgia developing after a COVID-19 vaccination. J Neurovirol. 2021."},{"issue":"5","key":"b10","series-title":"Praxis (Bern)","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1024\/0369-8394.91.5.159","article-title":"Vermutete neurologische Nebenwirkungen der FSME-Impfung: Erfahrung der Schweizerischen Arzneimittel-Nebenwirkungs-Zentrale (SANZ)","volume":"91","author":"Doser K","year":"2002","unstructured":"Doser K, Hartmann F. Vermutete neurologische Nebenwirkungen der FSME-Impfung: Erfahrung der Schweizerischen Arzneimittel-Nebenwirkungs-Zentrale (SANZ). Praxis (Bern). 2002;91(5):159\u2013162.10.1024\/0369-8394.91.5.159"},{"issue":"3","key":"b11","series-title":"Headache","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/head.14075","article-title":"Trigeminal neuralgia as the sole neurological manifestation of COVID-19: a case report","volume":"61","author":"Molina-Gil J","year":"2021","unstructured":"Molina-Gil J, Gonz\u00e1lez-Fern\u00e1ndez L, Garc\u00eda-Cabo C. Trigeminal neuralgia as the sole neurological manifestation of COVID-19: a case report. Headache. 2021;61(3):560\u2013562.10.1111\/head.14075"},{"issue":"7","key":"b12","series-title":"ACS Chem Neurosci","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig AM","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995\u2013998.10.1021\/acschemneuro.0c00122"},{"issue":"8","key":"b13","series-title":"Headache","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/head.13884","article-title":"COVID-19 and headache: a primer for trainees","volume":"60","author":"Bobker SM","year":"2020","unstructured":"Bobker SM, Robbins MS. COVID-19 and headache: a primer for trainees. Headache. 2020;60(8):1806\u20131811.10.1111\/head.13884"}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/3\/16\/article-CASE22101.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/3\/16\/article-CASE22101.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/3\/16\/article-CASE22101.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:44:43Z","timestamp":1770302683000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/3\/16\/article-CASE22101.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":26,"journal-issue":{"issue":"16"},"URL":"https:\/\/doi.org\/10.3171\/case22101","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]}}}